{"id":8628,"date":"2023-07-21T17:11:09","date_gmt":"2023-07-21T09:41:09","guid":{"rendered":"https:\/\/abtvn.com\/?post_type=product&p=8628"},"modified":"2026-05-20T15:18:55","modified_gmt":"2026-05-20T07:48:55","slug":"abt-dna-genotype-qpcr-kit-hpv-sqh-003","status":"publish","type":"product","link":"https:\/\/abtvn.com\/en\/product\/abt-dna-genotype-qpcr-kit-hpv-sqh-003\/","title":{"rendered":"ABT\u00ae DNA GENOTYPE qPCR KIT (SQH-003) (GENOTYPING OF HPV DNA)"},"content":{"rendered":"

 <\/p>\n

HPV introduction<\/h5>\n

 <\/p>\n

Human Papillomavirus <\/em> (HPV<\/a>) is a common sexually transmitted DNA virus. It is recognized as the etiological agent of a spectrum of diseases in both males and females, including precancerous lesions that may progress to malignancy and the formation of genital warts.<\/p>\n

Although the majority of HPV infections are asymptomatic and resolve spontaneously, persistent infection can lead to pathology. In women, chronic infection with specific high-risk genotypes\u2014most notably types 16 and 18\u2014can induce precancerous cervical lesions that, if untreated, may advance to invasive cervical carcinoma. HPV is also implicated in oropharyngeal and anogenital cancers as well as other disease entities in both sexes.<\/p>\n

More than 100 HPV genotypes have been identified, each designated by a numerical identifier. Certain low-risk genotypes cause anogenital warts but lack oncogenic potential. However, nearly all cases of cervical cancer (approximately 99 percent) are attributable to genital HPV infection. Fourteen high-risk genotypes are classified as carcinogenic\u2014types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68\u2014with types 16 and 18 together accounting for roughly 70 percent of global cervical cancer cases.<\/p>\n

ABT\u00ae DNA Genotype qPCR Kit<\/strong> is a diagnostic assay designed for qualitative detection of HPV DNA from 14 high-risk genotypes, with specific identification of genotypes 16 and 18. Samples are extracted from cervical swab or biopsy specimens and analyzed using Real-time PCR technology. Notably, the kit incorporates an endogenous RP internal control to effectively monitor sample collection, nucleic acid extraction, and PCR amplification processes. The results obtained from this diagnostic reagent are intended for clinical reference only and must not be used as the sole basis for diagnosis or exclusion of disease.<\/p>\n

\u00a0<\/em><\/p>\n

Advantages<\/strong><\/h5>\n

 <\/p>\n